Delivery Order SPE2DB22D2206-SPE2DB24FGK03
Award Date 3/29/24
Potential Completion Date 4/19/24
Potential Value $106K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $89,155.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,951,671 units of the medication REVLIMID 25 MG CAPSULE 100S, with a performance period through May 7, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $178,310.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REVLIMID 10 MG CAPSULE 100S, a medical product, with an ultimate completion date of February 4, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $28,471.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, with a completion date of January 8, 2024. This is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is an established prime contractor providing a wide range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $178,310.12, is a Firm Fixed Price Delivery Order for the supply of REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025 and was awarded on March 21, 2025. The contract is not designated with a set-aside requirement, indicating open...
- The U.S. Defense Logistics Agency (DLA) awarded a $49,926.80 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the supply of 10 mg REVLIMID capsules, a pharmaceutical product, to support government healthcare programs. The contract has an ultimate completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these critical medical commodities without any set-aside designation....
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price of $106,870.16 and a completion date of July 27, 2022. The contract was not set aside for any specific business type....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,963.40, is a Firm Fixed Price Delivery Order for the supply of REVLIMID 5 MG CAPSULE 28S. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $24,963.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, and has an ultimate completion date of October 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $46,660.58 firm fixed-price delivery order is for the supply of REVLIMID 2.5 MG CAPSULE 28S, a prescription medication. The contract has an ultimate completion date of May 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of drugs and medical supplies to various U.S. government agencies, particularly the...
- This federal contract award is for the delivery of the pharmaceutical drug Revlimid (10 mg capsule, 28-count) to the Defense Logistics Agency (DLA). The $23,330.28 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract, which has no set-aside designation, has a completion date of June 5, 2024. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...